Borviz 2.5 Injection
52,21$
42,60$
Borviz 2.5 mg Injection is a targeted anticancer therapy specifically designed to combat multiple myeloma and mantle cell lymphoma, both of which are aggressive blood cancers. The active ingredient, Bortezomib, works by inhibiting certain proteins within cancer cells, effectively disrupting their survival and leading to cell death. This innovative treatment is administered through injection, allowing for efficient absorption and action within the body. Patients receiving Borviz should be aware of potential side effects, including nausea, fatigue, and increased risk of infection, and should consult their healthcare provider for regular monitoring. It’s crucial to discuss your medical history and any existing health conditions with your doctor before starting this therapy. By targeting the mechanisms that allow cancer cells to thrive, Borviz 2.5 mg offers a promising option for those battling these challenging malignancies. Always follow your healthcare professional’s guidance regarding dosage and administration to ensure optimal treatment outcomes. Embrace the potential of Borviz in your cancer treatment journey, as it represents a significant advancement in modern oncology.
Quantité
Active Pharmaceutical Ingredient
Uses
• Borviz •5 injection is primarily utilized in the treatment of multiple myeloma, a type of cancer that impacts plasma cells. These abnormal plasma cells can disrupt normal blood cell production in the bone marrow. Patients often experience symptoms such as bone pain, fatigue, and recurrent infections. By addressing the underlying issues of plasma cell proliferation, Borviz •5 injection helps improve patients' quality of life.
• Another significant use of Borviz •5 injection is in the management of mantle cell lymphoma, a rare but aggressive form of non-Hodgkin lymphoma. This condition arises from B cells, which are essential for the immune response. Symptoms may include swollen lymph nodes, fever, and unintentional weight loss. By targeting the malignant B cells, Borviz •5 injection plays a critical role in controlling the disease and alleviating associated symptoms.
• Borviz •5 injection may also be indicated for patients with relapsed or refractory multiple myeloma. In these cases, the disease has either returned or has not responded to previous treatments. The injection helps by targeting the resistant cancer cells, potentially leading to better outcomes for patients who have exhausted other therapeutic options. This use underscores the importance of Borviz •5 injection in providing new avenues for treatment.
• Additionally, Borviz •5 injection can be considered for patients with aggressive mantle cell lymphoma who require prompt intervention. Given the rapid progression of this lymphoma, timely treatment is crucial. The injection is designed to help manage the disease effectively while minimizing the risk of complications. Thus, Borviz •5 injection serves as a vital therapeutic option in the oncology landscape.
Benefits
Borviz 2.5 mg contains the active substance bortezomib, also-called ‘proteasome inhibitor. Proteasomes play an important role in controlling cell function and growth. By interfering with their function, thereby it can kill cancer cells. Bortezomib Injection 2.5 mg is used to treat multiple myeloma (a cancer of the bone marrow) and mantle cell lymphoma (a type of cancer affecting the lymph nodes) in 18 years or older patients. It may be used alone or together with other medicines.
Side Effects
Like all medications, Borviz 2.5 mg can cause side effects but do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.
Most Common Side Effects
• Burning feeling of skin
• Stomach Pain
• Insomnia
• Dehydration
• Pneumonia
• High fever
Common Side Effects
• High Blood Pressure
• Tiredness
• Cough
• Chest Tightness
• Feet Swelling
How To Use
Borviz 2.5 mg is administered intravenously or subcutaneously at a hospital or clinic setting by a doctor or nurse. Your doctor will decide the right time to take the injection, so always follow your doctor's advice. The dose and how often you take it depends on what you are taking it for. You might be prescribed certain other medicine as a part of your treatment. You should take this medicine for as long as it is prescribed for you.
Safety Advice
• Alcohol: Consumption of alcohol is not recommended while using Borviz 2.5 mg. Alcohol may increase or decrease the effectiveness of the medicine and also increase the risk of side effects. It is the best advice for you before consuming alcohol, you can talk with a doctor or pharmacist, and they will tell you consumption of alcohol is safe or not.
• Kidney: Borviz 2.5 mg should be used with caution in patients with kidney disease. It is important that patients with kidney disease closely monitor kidney function while taking Bortezomib Injection 2.5 mg and report any unusual symptoms or changes in kidney function to their doctor. Your doctor may need to be adjusted the dose in such kidney disease patients.
• Breastfeeding: It is unknown whether Borviz 2.5 mg is excreted in human milk. If you are breastfeeding and taking this medicine. It is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for your and your baby's health.
• Liver: Borviz 2.5 mg should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Bortezomib Injection 2.5 mg and report any unusual symptoms or changes in liver function to their doctor. Your doctor may need to be adjusted the dose in such liver disease patients.
• Pregnancy: Animal reproduction studies have not been conducted with Borviz 2.5 mg. Bortezomib Injection 2.5 mg generally consider unsafe during pregnancy. If you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Borviz 2.5 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Borviz 2.5 mg will not affect your ability to drive or operate machinery. In case you experience any side effects while taking Bortezomib Injection 2.5 mg such as dizziness or drowsiness, it is important to avoid driving or operating heavy machinery until the side effects have resolved.